Skip to main content

Creative Planning

Position in NVO — Novo Nordisk A S

CIK 1540235 OVERLAND PARK, KS

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$30,974,368
+$14,399,347 QoQ
Shares Held
646,107
+43.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#73
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Jun 30, 2025
CallValue
$30
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Creative Planning holds $1,825,978,859 across 16 Drug Manufacturers - General names. NVO ranks #11 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVO

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,974,368 646,107
2026-03-31 $16,575,021 451,021
2025-12-31 $20,011,764 393,313
2025-09-30 $20,677,903 372,642
2025-06-30 $25,684,481 372,131
2025-06-30 $30 100
2025-03-31 $20,855,956 300,345
2024-12-31 $26,547,663 308,622
2024-09-30 $35,101,716 294,799
2024-06-30 $40,195,003 281,596
2024-03-31 $33,223,242 258,748
2023-12-31 $22,482,063 217,323
2023-09-30 $17,237,404 189,547
2023-06-30 $14,221,619 87,880
2023-03-31 $12,503,628 78,570
2022-12-31 $10,132,093 74,864
2022-09-30 $7,200,957 72,277
2022-06-30 $7,442,632 66,792
2022-03-31 $6,327,517 56,979
2021-12-31 $6,240,640 55,720
2021-09-30 $5,669,870 59,055
2021-06-30 $5,437,008 64,904
2021-03-31 $6,178,571 91,643
2020-12-31 $7,937,404 113,635
2020-09-30 $1,940,013 27,942
2020-06-30 $1,517,106 23,169
2020-03-31 $1,902,861 31,609